The trademark application C³urcumin+ was filed by KEYPHARM NV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). Application refused.
The application was filed in Dutch (English was selected as the second language).
The Refusal with reference B 018452091 was Rejected according to Article 7(1)(b) EUTMR with decision issued on October 19, 2021 by the EUIPO.